EP Patent

EP2621496A4 — NALOXOL-PEG CRYSTALLINE CONJUGATE

Assigned to AstraZeneca AB · Expires 2014-09-24 · 12y expired

What this patent protects

Patent listed against naloxegol-oxalate.

Drugs covered by this patent

naloxegol-oxalate (NALOXEGOL OXALATE)

Patent Metadata

Patent number: EP2621496A4
Jurisdiction: EP
Classification: —
Expires: 2014-09-24
Drug substance claim: No
Drug product claim: No
Assignee: AstraZeneca AB
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.